CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+7.99%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$9.63B
AUM Growth
+$9.63B
(+4.2%)
Cap. Flow
-$156M
Cap. Flow
% of AUM
-1.62%
Top 10 Holdings %
Top 10 Hldgs %
56.17%
Holding
92
New
3
Increased
16
Reduced
36
Closed
1
Top Buys
| 1 |
Parker-Hannifin
PH
|
$155M |
| 2 |
HDFC Bank
HDB
|
$21.9M |
| 3 |
Linde
LIN
|
$20.3M |
| 4 |
Ferguson
FERG
|
$18.4M |
| 5 |
Clean Harbors
CLH
|
$8.48M |
Top Sells
| 1 |
Microsoft
MSFT
|
$186M |
| 2 |
Costco
COST
|
$139M |
| 3 |
ResMed
RMD
|
$13M |
| 4 |
Service Corp International
SCI
|
$12.5M |
| 5 |
A.O. Smith
AOS
|
$8.95M |
Sector Composition
| 1 | Financials | 19.66% |
| 2 | Technology | 18.56% |
| 3 | Healthcare | 16.62% |
| 4 | Industrials | 11.41% |
| 5 | Consumer Discretionary | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
DexCom
DXCM
$30.9B
| $23.4M | 0.24% |
349,000
| – | – |
|
52
Cognex
CGNX
$7.38B
| $21.8M | 0.23% |
539,220
-1,845
| -0.3% | -$74.7K |
|
53
BioMarin Pharmaceuticals
BMRN
$11.3B
| $21.4M | 0.22% |
303,851
| – | – |
|
54
Align Technology
ALGN
$9.59B
| $21.2M | 0.22% |
83,428
+20,000
| +32% | +$5.09M |
|
55
Glaukos
GKOS
$5.42B
| $21.1M | 0.22% |
162,212
-15,000
| -8% | -$1.95M |
|
56
Infosys
INFY
$69B
| $19.4M | 0.2% |
870,516
+19,967
| +2% | +$445K |
|
57
Penumbra
PEN
$10.5B
| $18.8M | 0.2% |
97,000
| – | – |
|
58
Tencent Music
TME
$38.5B
| $18.3M | 0.19% |
1,522,251
+43,774
| +3% | +$527K |
|
59
Sarepta Therapeutics
SRPT
$1.98B
| $17.5M | 0.18% |
140,329
| – | – |
|
60
Humana
HUM
$37.5B
| $16.6M | 0.17% |
52,459
| – | – |
|
61
Teleflex
TFX
$5.57B
| $14.3M | 0.15% |
58,000
| – | – |
|
62
Zai Lab
ZLAB
$3.48B
| $12.1M | 0.13% |
500,000
| – | – |
|
63
Ionis Pharmaceuticals
IONS
$9.64B
| $12M | 0.12% |
300,000
| – | – |
|
64
Iovance Biotherapeutics
IOVA
$800M
| $11.8M | 0.12% |
1,260,000
| – | – |
|
65
Privia Health
PRVA
$2.84B
| $11.1M | 0.12% |
610,000
| – | – |
|
66
Neurocrine Biosciences
NBIX
$13.5B
| $10.9M | 0.11% |
95,000
+20,000
| +27% | +$2.3M |
|
67
Illumina
ILMN
$15.2B
| $10.2M | 0.11% |
77,978
| – | – |
|
68
NovoCure
NVCR
$1.35B
| $8.16M | 0.08% |
521,784
| – | – |
|
69
iRhythm Technologies
IRTC
$5.67B
| $5.94M | 0.06% |
80,000
| – | – |
|
70
Roper Technologies
ROP
$56.4B
| $3.07M | 0.03% |
+5,520
| New | +$3.07M |
|
71
Amdocs
DOX
$9.31B
| $2.4M | 0.02% |
27,400
| – | – |
|
72
Brookfield Renewable
BEPC
$5.92B
| $2.3M | 0.02% |
70,545
| – | – |
|
73
Sandstorm Gold
SAND
$3.29B
| $2.17M | 0.02% |
361,812
| – | – |
|
74
Genpact
G
$7.88B
| $2.15M | 0.02% |
54,738
| – | – |
|
75
McKesson
MCK
$85.9B
| $2.14M | 0.02% |
4,332
| – | – |
|